Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

Performance of Common Genetic Variants in Breast-Cancer Risk Models

(2010) Sholom Wacholder et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 6q22.33 Locus and Breast Cancer Susceptibility

(2009) T. Kirchhoff et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Assessing the Performance of Prediction Models

(2009) Ewout W. Steyerberg et al.   EPIDEMIOLOGY

Value of Adding Single-Nucleotide Polymorphism Genotypes to a Breast Cancer Risk Model

(2009) Mitchell H. Gail   JNCI-Journal of the National Cancer Institute

Risk of Estrogen Receptor–Positive and –Negative Breast Cancer and Single–Nucleotide Polymorphism 2q35-rs13387042

(2009) Roger L. Milne et al.   JNCI-Journal of the National Cancer Institute

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

(2009) Gilles Thomas et al.   NATURE GENETICS

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

(2009) Shahana Ahmed et al.   NATURE GENETICS

Beyond odds ratios — communicating disease risk based on genetic profiles

(2009) Peter Kraft et al.   NATURE REVIEWS GENETICS

Association of Genetic Variants at 8q24 with Breast Cancer Risk

(2008) O. Fletcher et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk

(2008) M. H. Gail   JNCI-Journal of the National Cancer Institute

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

(2008) Simon N Stacey et al.   NATURE GENETICS

Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33

(2008) B. Gold et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA